Gewinn- und Verlustrechnung von Abbott Laboratories

Both Medtronic and Abbott have dropped in 2026, and those declines reshuffled the math on yield, valuation, and long-term growth in ways that push retirement investors toward a clear but maybe surprising choice.

Park National Corp OH lessened its position in shares of Abbott Laboratories (NYSE: ABT) by 6.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 139,913 shares of the healthcare product maker's stock after selling 10,269 shares during

Eastern Bank trimmed its position in Abbott Laboratories (NYSE: ABT) by 14.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 56,544 shares of the healthcare product maker's stock after selling 9,287 shares during the period. Eastern Bank's holdings in Abbott Laboratories were worth $5,588,000 as

For the first time, U.S. CardioMEMS patients will be able to view pulmonary artery pressure (PAP) readings and receive personalized medication updates through the CardioGuide HF App Rising PAP can signal worsening heart failure weeks before patients experience symptoms New capabilities help patients take a more active role in their care and stay connected to their care teams between doctor visits ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.

Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.

ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Stocks clawed back from a wild Thursday session, oil surged past $100, and Wall Street analysts reshuffled their bets on names from Airbnb to Northrop Grumman. Find out which stocks got upgraded, downgraded, or newly covered heading into the first Friday of Q4 2026.

Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.

Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, and nutrition. Intuitive Surgical maintains a dominant lead in robotic-assisted surgery with high recurring revenue from instruments and services.